Cargando…

High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia

BACKGROUND: Hepatitis B virus (HBV) infections are common and associated with significant morbidity and mortality in cancer patients. However, the incidence and risk factors of HBV reactivation in patients with acute myeloid leukemia (AML) are rarely investigated. METHODS: AML patients followed-up a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chien-Yuan, Huang, Sheng-Yi, Cheng, Aristine, Chou, Wen-Chien, Yao, Ming, Tang, Jih-Luh, Tsay, Woei, Sheng, Wang-Huei, Tien, Hwei-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431821/ https://www.ncbi.nlm.nih.gov/pubmed/25973905 http://dx.doi.org/10.1371/journal.pone.0126037

Ejemplares similares

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
por: Huang, Huai-Hsuan, et al.
Publicado: (2019)

Intracranial hemorrhage in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2012)

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
por: Cheng, Chieh-Lung, et al.
Publicado: (2015)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan
por: Tang, Jih-Luh, et al.
Publicado: (2015)

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
por: Tsai, Cheng-Hong, et al.
Publicado: (2017)

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2014)

Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study
por: Huang, Shang-Yi, et al.
Publicado: (2015)

Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia
por: Chen, Yin-Kai, et al.
Publicado: (2015)

Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
por: Tsai, Cheng-Hong, et al.
Publicado: (2019)

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
por: Wang, Yu-Hung, et al.
Publicado: (2020)

Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2016)

Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2019)

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
por: Tien, Feng-Ming, et al.
Publicado: (2018)

High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017)

Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
por: Lin, Shih-Chiang, et al.
Publicado: (2022)

Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
por: Ko, Bor-Sheng, et al.
Publicado: (2018)

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
por: Yao, Chi-Yuan, et al.
Publicado: (2016)

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
por: Chuang, Ming-Kai, et al.
Publicado: (2015)

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
por: Wang, Yu-Hung, et al.
Publicado: (2020)

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma
por: Chen, Wan-Yu, et al.
Publicado: (2013)

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
por: Lin, Ming-En, et al.
Publicado: (2018)

Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
por: Chiang, Yun, et al.
Publicado: (2016)

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
por: Hou, Hsin-An, et al.
Publicado: (2018)

Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
por: Tsai, Xavier Cheng-Hong, et al.
Publicado: (2023)

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
por: Hou, Hsin-An, et al.
Publicado: (2020)

P721: VALIDATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DEFINED BY INTERNATIONAL CONSENSUS CLASSIFICATION
por: Hsuan Lee, Wan, et al.
Publicado: (2023)

Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
por: Wang, Yu‐Hung, et al.
Publicado: (2021)

PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
por: Lee, Sze‐Hwei, et al.
Publicado: (2021)

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
por: Lin, Chien-Chin, et al.
Publicado: (2017)

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
por: Lee, Wan-Hsuan, et al.
Publicado: (2023)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification
por: Wilop, Stefan, et al.
Publicado: (2016)

A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia
por: Ni, Sao‐Chih, et al.
Publicado: (2023)

Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications
por: Wu, Shang-Ju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_24j3ve7rvmbg6c0lti0h2lfeam